export default function OncologyIntro() {
  return (
    <section className="py-0">
      <div className="container-fluid">
        <div className="bg-gradient-to-br from-teal-600 to-teal-700 text-white p-8 lg:p-8 flex items-center">
          <div className="w-full">
            <h2 className="text-3xl font-bold text-white mb-6 leading-tight">
              Turning Complexity into Clarity
            </h2>
            <ul className="space-y-4">
              <li className="flex items-start gap-3">
                <div className="w-2 h-2 rounded-full mt-2 flex-shrink-0" style={{backgroundColor: '#faae31'}}></div>
                <span className="leading-relaxed text-justify">
                  Cancer is not a single disease—it's a highly complex and dynamic group of disorders, 
                  often driven by a multitude of genomic alterations. Despite advancements in treatment, 
                  many patients still face uncertainty due to incomplete or delayed molecular diagnoses.
                </span>
              </li>
              <li className="flex items-start gap-3">
                <div className="w-2 h-2 rounded-full mt-2 flex-shrink-0" style={{backgroundColor: '#faae31'}}></div>
                <span className="leading-relaxed text-justify">
                  At Operify Health, we recognize that behind every tumor is a unique genetic story waiting 
                  to be told. Our precision oncology solutions utilize high-throughput Next Generation 
                  Sequencing (NGS) to analyze both somatic and germline mutations—providing clinicians 
                  with actionable insights that inform targeted therapies, immunotherapy decisions, and 
                  hereditary cancer risk assessments.
                </span>
              </li>
              <li className="flex items-start gap-3">
                <div className="w-2 h-2 rounded-full mt-2 flex-shrink-0" style={{backgroundColor: '#faae31'}}></div>
                <span className="leading-relaxed text-justify">
                  This genomic-driven approach is especially critical in advanced and treatment-resistant 
                  cancers, where conventional methods often fall short. Studies have shown that integrating 
                  broad-panel NGS into cancer care can impact clinical decision-making in up to 30% of cases, 
                  leading to more personalized and effective treatment strategies.
                </span>
              </li>
              <li className="flex items-start gap-3">
                <div className="w-2 h-2 rounded-full mt-2 flex-shrink-0" style={{backgroundColor: '#faae31'}}></div>
                <span className="leading-relaxed text-justify">
                  By combining cutting-edge sequencing, advanced bioinformatics, and curated clinical evidence, 
                  Operify Health empowers oncologists to move from uncertainty to precision—ensuring every cancer 
                  patient's care is as individualized as their diagnosis.
                </span>
              </li>
            </ul>
          </div>
        </div>
      </div>
    </section>
  );
}